Compare with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DIVIS LABORATORIES ALKEM LABORATORIES/
DIVIS LABORATORIES
 
P/E (TTM) x - 35.6 - View Chart
P/BV x 7.2 6.6 108.1% View Chart
Dividend Yield % 0.6 0.9 65.6%  

Financials

 ALKEM LABORATORIES   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
DIVIS LABORATORIES
Mar-19
ALKEM LABORATORIES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,5891,639 96.9%   
Low Rs1,2321,115 110.5%   
Sales per share (Unadj.) Rs417.5186.3 224.1%  
Earnings per share (Unadj.) Rs56.351.0 110.5%  
Cash flow per share (Unadj.) Rs64.757.3 112.9%  
Dividends per share (Unadj.) Rs12.7016.00 79.4%  
Dividend yield (eoy) %0.91.2 77.5%  
Book value per share (Unadj.) Rs292.9261.8 111.9%  
Shares outstanding (eoy) m119.57265.47 45.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.47.4 45.7%   
Avg P/E ratio x25.127.0 92.7%  
P/CF ratio (eoy) x21.824.0 90.7%  
Price / Book Value ratio x4.85.3 91.5%  
Dividend payout %22.631.4 71.8%   
Avg Mkt Cap Rs m168,653365,592 46.1%   
No. of employees `000NA11.8 0.0%   
Total wages/salary Rs m9,1715,423 169.1%   
Avg. sales/employee Rs ThNM4,175.1-  
Avg. wages/employee Rs ThNM457.7-  
Avg. net profit/employee Rs ThNM1,141.8-  
INCOME DATA
Net Sales Rs m49,91549,463 100.9%  
Other income Rs m1,6451,556 105.7%   
Total revenues Rs m51,56151,019 101.1%   
Gross profit Rs m8,48218,718 45.3%  
Depreciation Rs m1,0061,689 59.6%   
Interest Rs m67135 1,916.0%   
Profit before tax Rs m8,45118,551 45.6%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6065,023 32.0%   
Profit after tax Rs m6,73113,527 49.8%  
Gross profit margin %17.037.8 44.9%  
Effective tax rate %19.027.1 70.2%   
Net profit margin %13.527.3 49.3%  
BALANCE SHEET DATA
Current assets Rs m27,06246,501 58.2%   
Current liabilities Rs m15,3248,468 181.0%   
Net working cap to sales %23.576.9 30.6%  
Current ratio x1.85.5 32.2%  
Inventory Days Days67131 50.8%  
Debtors Days Days4186 48.1%  
Net fixed assets Rs m12,61025,797 48.9%   
Share capital Rs m239531 45.0%   
"Free" reserves Rs m34,49068,962 50.0%   
Net worth Rs m35,02769,493 50.4%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38780,383 67.7%  
Interest coverage x13.6531.0 2.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 149.2%   
Return on assets %13.616.9 80.7%  
Return on equity %19.219.5 98.7%  
Return on capital %24.926.7 92.9%  
Exports to sales %12.90-   
Imports to sales %3.124.6 12.5%   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,54012,187 12.6%   
Fx inflow Rs m6,56341,238 15.9%   
Fx outflow Rs m3,01212,405 24.3%   
Net fx Rs m3,55228,833 12.3%   
CASH FLOW
From Operations Rs m7,2599,543 76.1%  
From Investments Rs m1,864-6,854 -27.2%  
From Financial Activity Rs m-9,273-2,459 377.0%  
Net Cashflow Rs m-150230 -65.3%  

Share Holding

Indian Promoters % 66.9 52.0 128.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 11.8 280.5%  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 17.2 -  
Shareholders   68,381 31,796 215.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  ASTRAZENECA PHARMA  AJANTA PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY19); Net Profit Up 68.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 68.9% YoY). Sales on the other hand came in at Rs 13 bn (up 29.4% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 18, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS